Drug trial tests new approach to calm sarcoidosis inflammation
Disease control
Terminated
This study tested whether the drug maraviroc could reduce harmful inflammation in the lungs of people with active sarcoidosis. Three participants took maraviroc for six weeks. Researchers compared immune cells from lung washings before and after treatment to see if the drug chang…
Phase: NA • Sponsor: Kevin F. Gibson • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC